Metraipolis › archive › dc_0bb8922dddbb

Leishmaniasis and vaccine development: current progress, challenges, and future perspectives — Europe PMC PMID:42923154

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42923154
DOI: 10.3389/fcimb.2026.1929424
License (as archived): solo-consultazione
Archived: 2026-11-01T07:15:55.182Z
SHA-256 of the archived text: 3ef97bdd8f969a1df868e9f4d800dd94d94fb242f4cf2b4a364555e8f0877d26
Stable URL of this page: https://metraipolis.com/documento/dc_0bb8922dddbb

How to cite

Leishmaniasis and vaccine development: current progress, challenges, and future perspectives — Europe PMC PMID:42923154 — Europe PMC (en), https://europepmc.org/article/MED/42923154 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bb8922dddbb (Metraipolis archive dc_0bb8922dddbb, sha256 3ef97bdd8f969a1df868e9f4d800dd94d94fb242f4cf2b4a364555e8f0877d26)

BibTeX

@misc{dc0bb8922dddbb,
  title = {Leishmaniasis and vaccine development: current progress, challenges, and future perspectives — Europe PMC PMID:42923154},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42923154},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bb8922dddbb; sha256 3ef97bdd8f969a1df868e9f4d800dd94d94fb242f4cf2b4a364555e8f0877d26},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42923154. Agents can read the archived copy with the MCP tool read_document.